ISMO Bio-Photonics, incubated at IIT Madras Research Park, offers vertically integrated design and manufacturing of microfluidic bioreactors, organ-on-chip systems, 3D bioprinting, and live cell imaging platforms for pharmaceutical research and diagnostics. The startup's organ-on-chip technology recreates human tissue microenvironments on microfluidic chips, enabling real-time disease modeling, personalized drug screening, and accelerated preclinical trials while reducing costs and ethical concerns associated with animal testing.

Their proprietary analytics and automation integrate fiber-laser–based imaging, opto-genomics, and AI-driven performance monitoring to deliver high-throughput assays with precise control over biochemical gradients and mechanical stimuli. ISMO conducts comprehensive in vitro biocompatibility tests—including cytotoxicity, genotoxicity, hemocompatibility, and irritation assays—to ensure device safety and regulatory compliance.

Committed to global leadership in medical devices, ISMO's collaborations span leading academic institutions and industry partners such as Pfizer and Mankind Pharma.

‍